{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:17:04Z","timestamp":1774952224905,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NEI R01\u2010EY\u201003,424"],"award-info":[{"award-number":["NEI R01\u2010EY\u201003,424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NEI R01\u2010EY\u201019,674"],"award-info":[{"award-number":["NEI R01\u2010EY\u201019,674"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OVS"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose.<\/jats:title>\n                    <jats:p>To evaluate the use of global indices summarizing the current status of a patient's visual field as predictors of their future rate of change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Ninety\u2010five subjects with early or suspected glaucoma were studied, of whom 50 exhibited glaucomatous optic neuropathy (GON) at baseline. Subjects underwent seven annual visual field tests. Results from the first test in the sequence were used to predict their subsequent rate of change. Two global indices were considered: mean deviation (MD) and pattern standard deviation (PSD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Using multiple linear regression, baseline MD predicted subsequent slope of MD significantly better than baseline PSD predicted subsequent slope of PSD (p = 0.017). Using multiple logistic regression, a worse initial MD was predictive of being in the worst tertile for subsequent change in MD (pseudo\u2010R\n                      <jats:sup>2<\/jats:sup>\n                      = 0.33 for subjects with GON at baseline and 0.31 for those without). Worse initial PSD was not predictive of being in the worst tertile for subsequent change in PSD (pseudo\u2010R\n                      <jats:sup>2<\/jats:sup>\n                      = 0.09 with GON at baseline, 0.10 without).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Among patients with otherwise similar clinical profiles, a worse visual field at baseline, as measured by the global index MD, is predictive of a more rapid future rate of change. This should be taken into account when clinical decisions are made concerning management of patients who already have some visual field damage at presentation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/opx.0b013e3181fc30b6","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T06:22:10Z","timestamp":1287037330000},"page":"56-62","source":"Crossref","is-referenced-by-count":19,"title":["Perimetric Indices as Predictors of Future Glaucomatous Functional Change"],"prefix":"10.1002","volume":"88","author":[{"given":"Stuart K.","family":"Gardiner","sequence":"first","affiliation":[{"name":"Discoveries in Sight Laboratories Devers Eye Institute Legacy Health Portland Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaban","family":"Demirel","sequence":"additional","affiliation":[{"name":"Discoveries in Sight Laboratories Devers Eye Institute Legacy Health Portland Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences University of Iowa Iowa City Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,1]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1167\/iovs.07-0866","article-title":"Estimating the rate of progressive visual field damage in those with open\u2010angle glaucoma, from cross\u2010sectional data","volume":"49","author":"Broman AT","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1167\/iovs.08-2843","article-title":"The glaucoma research community and FDA look to the future: a report from the NEI\/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium","volume":"50","author":"Weinreb RN","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske MC","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","volume":"111","author":"Nouri\u2010Mahdavi K","year":"2004","journal-title":"Ophthalmology"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open\u2010angle glaucoma","volume":"120","author":"Gordon MO","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ajo.2004.04.058","article-title":"An evidence\u2010based assessment of risk factors for the progression of ocular hypertension and glaucoma","volume":"138","author":"Friedman DS","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archopht.125.8.1010","article-title":"Long\u2010term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure","volume":"125","author":"Hong S","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9394(01)00964-3","article-title":"Risk factors for progression of visual field abnormalities in normal\u2010tension glaucoma","volume":"131","author":"Drance S","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2006.07.060","article-title":"Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial","volume":"114","author":"Bengtsson B","year":"2007","journal-title":"Ophthalmology"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ajo.2007.12.003","article-title":"The importance of rates in glaucoma","volume":"145","author":"Caprioli J","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.ijg.0000145813.46848.b8","article-title":"Psychophysical investigation of ganglion cell loss in early glaucoma","volume":"14","author":"Spry PG","year":"2005","journal-title":"J Glaucoma"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1167\/iovs.05-0266","article-title":"Evaluation of the structure\u2010function relationship in glaucoma","volume":"46","author":"Gardiner SK","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_14_1","volume-title":"Automated Static Perimetry","author":"Anderson DR","year":"1999"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0420.1997.tb00392.x","article-title":"A new generation of algorithms for computerized threshold perimetry, SITA","volume":"75","author":"Bengtsson B","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1167\/iovs.06-0561","article-title":"Comparing multifocal VEP and standard automated perimetry in high\u2010risk ocular hypertension and early glaucoma","volume":"48","author":"Fortune B","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9394(02)01577-5","article-title":"Structure and function evaluation (SAFE): I. criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP)","volume":"134","author":"Johnson CA","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1037\/0033-2909.87.2.245","article-title":"Tests for comparing elements of a correlation matrix","volume":"87","author":"Steiger J","year":"1980","journal-title":"Psychol Bull"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archophthalmol.2010.20","article-title":"Delaying treatment of ocular hypertension: the ocular hypertension treatment study","volume":"128","author":"Kass MA","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike H","year":"1974","journal-title":"IEEE Trans Automatic Control"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/biomet\/78.3.691","article-title":"A note on a general definition of the coefficient of determination","volume":"78","author":"Nagelkerke NJ","year":"1991","journal-title":"Biometrika"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1167\/iovs.08-1767","article-title":"Predicting progressive glaucomatous optic neuropathy using baseline standard automated perimetry data","volume":"50","author":"Demirel S","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_23_1","first-page":"436","article-title":"Senescent changes of the normal visual field: an age\u2010old problem","volume":"78","author":"Spry PG","year":"2001","journal-title":"Optom Vis Sci"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1167\/iovs.05-0827","article-title":"Visual field progression in glaucoma: total versus pattern deviation analyses","volume":"46","author":"Artes PH","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1001\/archopht.1987.01060110090039","article-title":"Normal variability of static perimetric threshold values across the central visual field","volume":"105","author":"Heijl A","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1167\/iovs.08-1753","article-title":"Age\u2010related losses of retinal ganglion cells and axons","volume":"49","author":"Harwerth RS","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archopht.117.1.24","article-title":"Comparison of conventional and high\u2010pass resolution perimetry in a prospective study of patients with glaucoma and healthy controls","volume":"117","author":"Chauhan BC","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajo.2007.09.038","article-title":"A visual field index for calculation of glaucoma rate of progression","volume":"145","author":"Bengtsson B","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_6_29_1","first-page":"3147","article-title":"Diffuse loss of sensitivity in early glaucoma","volume":"40","author":"Henson DB","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_30_1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0002-9394(84)90242-3","article-title":"Diffuse and localized nerve fiber loss in glaucoma","volume":"98","author":"Airaksinen PJ","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/bjo.2009.158097","article-title":"Visual field index rate and event\u2010based glaucoma progression analysis: comparison in a glaucoma population","volume":"93","author":"Casas\u2010Llera P","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"e_1_2_6_32_1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open\u2010angle glaucoma","volume":"120","author":"Kass MA","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_33_1","article-title":"A new implantable system for telemetric IOP monitoring in nonhuman primates (NHP)","volume":"49","author":"Downs J","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_34_1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0042-6989(03)00474-7","article-title":"Reducing noise in suspected glaucomatous visual fields by using a new spatial filter","volume":"44","author":"Gardiner SK","year":"2004","journal-title":"Vision Res"},{"key":"e_1_2_6_35_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1167\/iovs.06-0576","article-title":"Monitoring glaucomatous visual field progression: the effect of a novel spatial filter","volume":"48","author":"Strouthidis NG","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_36_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archopht.120.2.173","article-title":"Spatial and temporal processing of threshold data for detection of progressive glaucomatous visual field loss","volume":"120","author":"Spry PG","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_37_1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2007.135012","article-title":"Practical recommendations for measuring rates of visual field change in glaucoma","volume":"92","author":"Chauhan BC","year":"2008","journal-title":"Br J Ophthalmol"}],"container-title":["Optometry and Vision Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e3181fc30b6","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1097\/OPX.0b013e3181fc30b6","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e3181fc30b6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:38:22Z","timestamp":1774949902000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/OPX.0b013e3181fc30b6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1097\/OPX.0b013e3181fc30b6"],"URL":"https:\/\/doi.org\/10.1097\/opx.0b013e3181fc30b6","archive":["Portico"],"relation":{},"ISSN":["1040-5488","1538-9235"],"issn-type":[{"value":"1040-5488","type":"print"},{"value":"1538-9235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}